ALD Connect, Inc.   Report issue

Foundation Phase 2
Founded: Boston MA United States (2013)

Organization Overview

First Clinical Trial
2016
NCT02595489
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now